Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIEE
FI Enhanced Europe 50 ETN
FIEE
|
+$334M |
| 2 |
Goldman Sachs
GS
|
+$280M |
| 3 |
Capital One
COF
|
+$81.6M |
| 4 |
NXP Semiconductors
NXPI
|
+$78.2M |
| 5 |
Lloyds Banking Group
LYG
|
+$70.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$267M |
| 2 |
Citigroup
C
|
+$175M |
| 3 |
Bank of America
BAC
|
+$112M |
| 4 |
CS
Credit Suisse Group
CS
|
+$109M |
| 5 |
American Express
AXP
|
+$77.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.39% |
| 2 | Technology | 14.47% |
| 3 | Healthcare | 13.22% |
| 4 | Consumer Discretionary | 8.36% |
| 5 | Industrials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Anika Therapeutics
ANIK
$258M
| $4.48M | 0.01% |
93,715
+35,996
| +62% | +$1.78M |
|
327
SS&C Technologies
SSNC
$18.1B
| $4.47M | 0.01% |
138,950
+118,900
| +593% | +$3.77M |
|
|
CATM
328
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $4.42M | 0.01% |
99,000
| – | – |
|
|
BRCD
329
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $4.36M | 0.01% |
472,345
-95,376
| -17% | -$889K |
|
330
Hyster-Yale Materials Handling
HY
$599M
| $4.22M | 0.01% |
70,169
| – | – |
|
331
Piper Sandler
PIPR
$5.12B
| $4.18M | 0.01% |
346,084
-93,320
| -21% | -$1.02M |
|
332
Ultrapar
UGP
$6.95B
| $4.09M | 0.01% |
373,980
-103,344
| -22% | -$1.15M |
|
|
LPT
333
DELISTED
Liberty Property Trust
LPT
| $4M | 0.01% |
99,163
-8,665
| -8% | -$350K |
|
334
State Street SPDR S&P Capital Markets ETF
KCE
$456M
| $3.95M | 0.01% |
+97,420
| New | +$3.86M |
|
335
ICU Medical
ICUI
$4.21B
| $3.92M | 0.01% |
31,000
| – | – |
|
336
Ironwood Pharmaceuticals
IRWD
$696M
| $3.85M | 0.01% |
289,485
| – | – |
|
|
CHL
337
DELISTED
China Mobile Limited
CHL
| $3.81M | 0.01% |
61,978
-365
| -0.6% | -$22.4K |
|
338
Amphastar Pharmaceuticals
AMPH
$879M
| $3.75M | 0.01% |
197,658
-52,673
| -21% | -$956K |
|
339
Energizer
ENR
$1.44B
| $3.75M | 0.01% |
75,038
+7,868
| +12% | +$386K |
|
340
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $3.75M | 0.01% |
46,507
+1,651
| +4% | +$133K |
|
|
CYNO
341
DELISTED
Cynosure, Inc. Class A
CYNO
| $3.73M | 0.01% |
73,253
-22,917
| -24% | -$1.19M |
|
|
GWB
342
DELISTED
Great Western Bancorp, Inc.
GWB
| $3.67M | 0.01% |
110,094
-29,522
| -21% | -$975K |
|
343
Vipshop
VIPS
$7.37B
| $3.53M | 0.01% |
+240,742
| New | +$3.38M |
|
344
Merit Medical Systems
MMSI
$5.08B
| $3.53M | 0.01% |
145,380
-40,417
| -22% | -$934K |
|
|
NPTN
345
DELISTED
NEOPHOTONICS CORP
NPTN
| $3.45M | 0.01% |
210,890
-73,989
| -26% | -$1.04M |
|
346
IBM
IBM
$211B
| $3.38M | 0.01% |
22,261
+594
| +3% | +$90.1K |
|
347
Check Point Software Technologies
CHKP
$13B
| $3.28M | 0.01% |
42,300
-1,300
| -3% | -$101K |
|
|
SFBS
348
ServisFirst Bancshares
SFBS
$4.89B
| $3.21M | 0.01% |
123,482
-33,536
| -21% | -$857K |
|
349
LivaNova
LIVN
$4.4B
| $3.13M | 0.01% |
52,000
| – | – |
|
|
DHC
350
Diversified Healthcare Trust
DHC
$2.15B
| $3.12M | 0.01% |
137,400
+43,700
| +47% | +$967K |
|
Similar funds
Ken Fisher's Q3 2016 Portfolio in Review
As of Q3 2016, Ken Fisher held 812 positions worth $56.3B, up 4.5% from $53.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher's Q3 2016 filing shows 67 new, 303 increased, 278 reduced and 36 closed positions. Its largest new stake was iShares Europe ETF: 130,527 shares worth $5.14M. The largest sale was Barclays ETN+ FI Enhanced Europe 50 ETN, an estimated $267M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q3 2016 buy was iShares Europe ETF: 130,527 shares worth $5.14M.
- Ken Fisher added most to FI Enhanced Europe 50 ETN in Q3 2016, an estimated $334M increase.
- Ken Fisher's biggest Q3 2016 reduction was Barclays ETN+ FI Enhanced Europe 50 ETN, cutting an estimated $267M.
- Ken Fisher fully exited PrivateBancorp Inc in Q3 2016, selling an estimated $61.3M.
- Ken Fisher's ten largest holdings make up 23% of its $56.3B portfolio in Q3 2016.
- Ken Fisher opened 67 new positions and closed 36 in Q3 2016.
- Ken Fisher's portfolio value rose 4.5% quarter-over-quarter to $56.3B.
Based on Fisher Asset Management's 13F filing for Q3 2016, filed 11 Oct 2016.